Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation.
about
Is fat taste ready for primetime?Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathwaysWhy do cannabinoid receptors have more than one endogenous ligand?The thrifty lipids: endocannabinoids and the neural control of energy conservationParabens inhibit fatty acid amide hydrolase: A potential role in paraben-enhanced 3T3-L1 adipocyte differentiationAnalysis and isolation of adipocytes by flow cytometry.Dietary triacylglycerols with palmitic acid in the sn-2 position modulate levels of N-acylethanolamides in rat tissuesPeripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation.N-Acylethanolamines Bind to SIRT6Anandamide-derived prostamide F2α negatively regulates adipogenesisNew vistas for treatment of obesity and diabetes? Endocannabinoid signalling and metabolism in the modulation of energy balance.β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: the role of eNOS, p38 MAPK, and AMPK pathways.18β-glycyrrhetinic acid attenuates anandamide-induced adiposity and high-fat diet induced obesity.An in vitro study reveals nutraceutical properties of Ananas comosus (L.) Merr. var. Mauritius fruit residue beneficial to diabetes.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Genetic interaction of DGAT2 and FAAH in the development of human obesity.Endocannabinoids and Schizophrenia.
P2860
Q22337316-3F83D344-DE97-4689-8163-14E236A3748FQ26823256-431541D1-1B02-4945-9786-778BF080756CQ26862444-6209DB4E-B607-44A6-924E-1D16E4B17BB5Q26996134-8DD2B694-F4E9-44D0-B4EE-033536129F03Q28393331-56BBA7D0-C805-49DD-B6A2-B4AAB880E356Q34083370-ACA658B0-ADCF-47BE-A6C0-2AC5AAB1F548Q35578640-7A78761E-F8D4-4E12-A842-16D62F37AC31Q35839912-6C279A94-E19B-4AE0-B0A0-AFD501BABC0FQ36744621-0F87F63B-DBB8-4F94-ADDE-6F5FB4EE7EC6Q37095444-28FD5D8E-9706-41A6-95B3-0D970050E248Q38016798-7A954F93-A593-4D44-85CB-2E4E2D897064Q42272971-1111AE22-2139-4A32-A1F7-BCEB23DC779DQ42398897-5A0AEF1F-5A56-4034-A3AF-58228DD43DE2Q42804678-1AF824A5-C5A6-4C87-BD9D-425F47EA3F83Q42815197-01EADEE6-7D98-4AB3-8660-EC1359795ECCQ45288843-5EC9B9AA-B1B6-42C7-912F-4BAEABB75723Q51119200-EA1987A6-EB38-4A7F-B110-40156D12C48AQ55452539-65645131-670A-46D1-8D5E-0E4731EF96AE
P2860
Anandamide increases the differentiation of rat adipocytes and causes PPARgamma and CB1 receptor upregulation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@en
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@nl
type
label
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@en
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@nl
prefLabel
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@en
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@nl
P2093
P2860
P356
P1433
P1476
Anandamide increases the diffe ...... and CB1 receptor upregulation.
@en
P2093
Athanasia Siafaka-Kapadai
Chrisanthi Gontinou
Katerina Psarra
Mary Mavri-Vavayanni
Sevasti Karaliota
P2860
P304
P356
10.1038/OBY.2009.177
P577
2009-06-18T00:00:00Z